Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ProPhase Labs Inc. PRPH

ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.


Recent & Breaking News (NDAQ:PRPH)

ProPhase Labs Reports Financial Results for the Three and Six Months Ended June 30, 2013

Marketwired August 13, 2013

ProPhase Labs Reports Financial Results for the First Quarter Ended March 31, 2013

Marketwired May 6, 2013

ProPhase Labs Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012

Marketwired March 26, 2013

Matrixx Initiatives Withdraws Acquisition Offer for ProPhase Labs

PR Newswire February 5, 2013